Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MeAxon Plus
- Development stage
- Unknown
- Lead developer
- Bion Therapeutics
- Modality
- Small Molecules
- Administration
- Injection
01
Overview
MeAxon Plus is an injectable nutraceutical and small-molecule combination product developed by Bion Therapeutics India Pvt Ltd. It is specifically formulated with methylcobalamin (1500 mcg), folic acid (0.7 mg), and niacinamide (12 mg) to address nutritional deficiencies and provide supportive care for metabolic and neurological disorders. Methylcobalamin, a coenzyme form of vitamin B12, is essential for nerve metabolism, myelin sheath formation, and red blood cell production. Folic acid (vitamin B9) serves as a critical precursor for DNA synthesis and cellular repair, while niacinamide (vitamin B3) acts as a precursor to nicotinamide adenine dinucleotide (NAD+), supporting cellular energy metabolism. The product is primarily indicated for the treatment of megaloblastic anemia, vitamin B12 and folate deficiencies, and as a supportive therapy for peripheral neuropathy. It is approved and marketed in India as a parenteral vitamin supplement.
- Brand names
- MeAxon Plus
- Other names
- MeAxon Plus InjectionMeAxon Plus Inj
02
Targets
DHFR (Dihydrofolate reductase)MTR (Methionine synthase)NAD (Nicotinamide adenine dinucleotide)
Beyond the preview
Go deeper on MeAxon Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MeAxon Plus.